Jefferies Downgrades Brightpoint (CELL)
Jefferies downgrades Brightpoint (NASDAQ: CELL) from a Buy to a Hold rating
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Brightpoint Inc. JefferiesAnalyst Color Downgrades Analyst Ratings